Pfizer 2014 Annual Report Download - page 46

Download and view the complete annual report

Please find page 46 of the 2014 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 75

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75

PFIZER ANNUAL REVIEW 2014 www.pzer.com/annual 46
ANNUAL REVIEW 2014
Our Science > Clinical Trials
INVESTIGATING WITH INTEGRITY
Clinical trials and the people who participate in them play a vital and heroic role
in bringing new breakthroughs to patients. Pfizer is committed to improving
the effectiveness and efficiency of clinical trials, while protecting the safety and
interests of clinical trial volunteers.
448
ACTIVE STUDIES FROM PHASE 1–4 INVOLVING
49,456 ACTIVE PATIENTS ACROSS 7,600 SITES IN 90
COUNTRIES AS OF DECEMBER 2014
CLINICAL TRIALS
We conduct our clinical trials, wherever they take place, to consistent
ethical standards, comply with applicable laws and regulations,
and fully protect the rights and welfare of trial participants. We
integrate quality management principles into the clinical trial process,
maintaining vigilant oversight over all trials, including those conducted
for us by contract research organizations. To assure patient safety,
data integrity, protocol adherence and regulatory compliance, we
routinely monitor clinical trial sites and audit the data generated
in studies.
CLINICAL INNOVATION
Pzer has created a discipline around clinical innovation, to make
research participation easier for patients and health care providers.
We are using new approaches and partnerships for clinical trial
recruitment, particularly in the drive to increase the diversity of
participants. Mobile health, social media and health information
technology offer new ways to capture data and insights from patients,
enhance the patient experience, and coordinate the clinical trials
conducted in partnership with thousands of independent researchers.
Pzer Link, an “alumni network” for study subjects who have
completed their participation in a Pzer-sponsored clinical trial, is a
unique online patient engagement tool that allows Pzer clinical trial
participants to be more active in the drug discovery and development
process. Pzer Link provides information on diseases and conditions
of interest, suggestions and tools for disease management,
opportunities to participate in future clinical trials, and access to
patient registries.
“Patients make an incredible contribution
when they choose to participate in a clinical
trial. We are actively nding ways to help
minimize burden on these patients and
make our studies more patient-friendly, from
making study participation locations more
convenient to using innovative digital tools to
collect data and share information.”
CRAIG LIPSET
HEAD OF CLINICAL
INNOVATION WITHIN
WORLDWIDE
RESEARCH &
DEVELOPMENT